Physician profile
Mark Sprague
NPI 1003942699
$33,474.65
in general payments reported to CMS, 2019-2025
8 companies · $401 in 2025
The $401 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,790 · 2020: $11K · 2021: $5,413 · 2022: $2,029 · 2023: $6,504 · 2024: $111 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,300 · Food and Beverage: $529 · Travel and Lodging: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,300.00 |
| Food and Beverage | $528.65 |
| Travel and Lodging | $187.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $31,225.58 | 2019-2025 | Coblation, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Kairos Surgical INC | $1,200.00 | 2022 | |
| Stryker Corporation | $705.61 | 2021-2025 | Mako |
| Depuy Synthes Sales INC. | $165.36 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $101.69 | 2020-2025 | Tapestry |
| Moximed, INC | $31.68 | 2025 | Misha Knee System, Small, Left |
| Convatec INC. | $23.36 | 2025 | |
| Vericel Corporation | $21.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sprague listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.